Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $266.71 million. The enterprise value is $173.12 million.
| Market Cap | 266.71M |
| Enterprise Value | 173.12M |
Important Dates
The last earnings date was Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 49.76 million shares outstanding. The number of shares has increased by 2.23% in one year.
| Shares Outstanding | 49.76M |
| Shares Change (YoY) | +2.23% |
| Shares Change (QoQ) | +1.20% |
| Owned by Insiders (%) | 20.65% |
| Owned by Institutions (%) | 50.92% |
| Float | 30.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.27 |
| Forward PS | 3.06 |
| PB Ratio | 2.44 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.01, with a Debt / Equity ratio of 0.31.
| Current Ratio | 13.01 |
| Quick Ratio | 12.22 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.24 |
Financial Efficiency
Return on equity (ROE) is -44.50% and return on invested capital (ROIC) is -38.09%.
| Return on Equity (ROE) | -44.50% |
| Return on Assets (ROA) | -32.00% |
| Return on Capital (ROIC) | -38.09% |
| Revenue Per Employee | $380,822 |
| Profits Per Employee | -$255,822 |
| Employee Count | 214 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.66 |
Taxes
In the past 12 months, Sight Sciences has paid $113,000 in taxes.
| Income Tax | 113,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.72% in the last 52 weeks. The beta is 2.72, so Sight Sciences's price volatility has been higher than the market average.
| Beta (1Y) | 2.72 |
| 52-Week Price Change | -44.72% |
| 50-Day Moving Average | 5.34 |
| 200-Day Moving Average | 4.56 |
| Relative Strength Index (RSI) | 46.96 |
| Average Volume (30 Days) | 161,396 |
Short Selling Information
The latest short interest is 1.38 million, so 2.77% of the outstanding shares have been sold short.
| Short Interest | 1.38M |
| Short Previous Month | 1.26M |
| Short % of Shares Out | 2.77% |
| Short % of Float | 4.54% |
| Short Ratio (days to cover) | 6.15 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $81.50 million and -$54.75 million in losses. Loss per share was -$1.12.
| Revenue | 81.50M |
| Gross Profit | 69.87M |
| Operating Income | -54.43M |
| Pretax Income | -54.63M |
| Net Income | -54.75M |
| EBITDA | -47.71M |
| EBIT | -49.30M |
| Loss Per Share | -$1.12 |
Balance Sheet
The company has $127.28 million in cash and $33.70 million in debt, giving a net cash position of $93.59 million or $1.88 per share.
| Cash & Cash Equivalents | 127.28M |
| Total Debt | 33.70M |
| Net Cash | 93.59M |
| Net Cash Per Share | $1.88 |
| Equity / Book Value | 109.21M |
| Book Value Per Share | 2.19 |
| Working Capital | 140.40M |
Cash Flow
In the last 12 months, operating cash flow was -$39.59 million and capital expenditures -$782,000, giving a free cash flow of -$40.37 million.
| Operating Cash Flow | -39.59M |
| Capital Expenditures | -782,000 |
| Free Cash Flow | -40.37M |
| FCF Per Share | -$0.82 |
Margins
Gross margin is 85.73%, with operating and profit margins of -66.79% and -67.18%.
| Gross Margin | 85.73% |
| Operating Margin | -66.79% |
| Pretax Margin | -67.04% |
| Profit Margin | -67.18% |
| EBITDA Margin | -58.55% |
| EBIT Margin | -60.49% |
| FCF Margin | -49.53% |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.23% |
| Shareholder Yield | -2.23% |
| Earnings Yield | -20.53% |
| FCF Yield | -15.14% |
Analyst Forecast
The average price target for Sight Sciences is $5.10, which is -4.49% lower than the current price. The consensus rating is "Hold".
| Price Target | $5.10 |
| Price Target Difference | -4.49% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of 1.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 4 |